Serum proteomic profiling of patients with compensated advanced chronic liver disease with and without clinically significant portal hypertension.

Serum proteomic profiling of patients with compensated advanced chronic liver disease with and without clinically significant portal hypertension.

<h4>Introduction</h4>Portal hypertension (PH) drives the progression of liver cirrhosis to decompensation and death. Hepatic venous pressure gradient (HVPG) measurement is the standard of PH quantification, and HVPG≥10 mmHg defines clinically significant PH (CSPH). We performed proteomic...

Full description

Bibliographic Details
Main Authors: Frane Pastrovic, Rudjer Novak, Ivica Grgurevic, Stela Hrkac, Grgur Salai, Marko Zarak, Lovorka Grgurevic
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0301416&type=printable

Internet

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0301416&type=printable

Similar Items